Achieving Targets in Secondary Prevention of Hyperlipidaemia in Patients with Coronary Artery Disease.
Sawalha, D., Abu Alsamen, D., Obaidat, D., Alhyari, D. (2013). Achieving Targets in Secondary Prevention of Hyperlipidaemia in Patients with Coronary Artery Disease.. EKB Journal Management System, 53(1), 1106-1109. doi: 10.12816/0001671
Dr Walid Sawalha; Dr Ashraf Ahmad Abu Alsamen; Dr Laith Saad Obaidat; Dr Ramzi Abdelmajeed Alhyari. "Achieving Targets in Secondary Prevention of Hyperlipidaemia in Patients with Coronary Artery Disease.". EKB Journal Management System, 53, 1, 2013, 1106-1109. doi: 10.12816/0001671
Sawalha, D., Abu Alsamen, D., Obaidat, D., Alhyari, D. (2013). 'Achieving Targets in Secondary Prevention of Hyperlipidaemia in Patients with Coronary Artery Disease.', EKB Journal Management System, 53(1), pp. 1106-1109. doi: 10.12816/0001671
Sawalha, D., Abu Alsamen, D., Obaidat, D., Alhyari, D. Achieving Targets in Secondary Prevention of Hyperlipidaemia in Patients with Coronary Artery Disease.. EKB Journal Management System, 2013; 53(1): 1106-1109. doi: 10.12816/0001671

Achieving Targets in Secondary Prevention of Hyperlipidaemia in Patients with Coronary Artery Disease.

The Egyptian Journal of Hospital Medicine
Article 36, Volume 53, Issue 1, October 2013, Page 1106-1109  XML PDF (175.78 K)
Document Type: Original Article
DOI: 10.12816/0001671
View on SCiNiTO View on SCiNiTO
Authors
Dr Walid Sawalha* ; Dr Ashraf Ahmad Abu Alsamen; Dr Laith Saad Obaidat; Dr Ramzi Abdelmajeed Alhyari
Queen Alia Heart Institute – King Hussein Medical Centre Amman – Jordan
Abstract
Abstract
Aim:
  We set our study to assess how good are we at achieving targets of lipid profile in patients with coronary artery disease at Queen Alia Heart Institute – King Hussein Medical Centre Amman – Jordan.
Method:
   This was a retrospective analysis of the lipid profile of patients who are being followed up for coronary artery disease at Queen Alia Heart Institute. Lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides) of patients who are legible for secondary prevention was collected and compared to the targets set by the Adult Treatment Panel (ATP) III guidelines. Demographic data and risk factors for coronary artery disease (CAD) were collected. The type and dose of lipid lowering drug was recorded.
Results;
    Lipid profiles of 1250 patients were looked at. Their age ranged from 29 – 76 years with a mean age of 59.6 years (±12.8). 27% of our study were females. The mean age for females was 64.2 years (±11.4) and for males was 57.4 years (±13.1). The prevalence of diabetes was 48.5%, hypertension 59.2%, hyperlipidaemia in 30%, family history of premature CAD 28% and 44% were smokers. Target total cholesterol was achieved in 67% of patients, and target LDL in 54% and HDL in 49% of patients. Almost all patients were on statins or fibrates (94%). 52% were on Simvastatin (84% of them on 20mg) and 38% on Atorvastatin (88% of them on 20mg).
Conclusion;
 Target lipid profile in our patients has only been moderately achieved in patients with coronary artery disease. Only modest doses of statins are used. More efforts with better follow up is needed.
 
 
Keywords
Coronary Artery Disease; Lipid profile; Jordan
Statistics
Article View: 111
PDF Download: 221